Therapy News and Research

RSS

Study reveals new information about role of abdominal fat in teens with CAH

Researchers at Children's Hospital Los Angeles have demonstrated that adolescents and young adults with congenital adrenal hyperplasia (CAH) have significantly increased amounts of abdominal fat tissue, placing them at greater risk for harmful conditions linked to obesity, including cardiovascular disease (CVD).

11 Jun 2015

SQUIRE phase III study shows necitumumab improves median overall survival in squamous NSCLC patients

This week, Lancet Oncology reports results of a 1,093-person phase III clinical trial of the drug necitumumab (IMC-11F8) combined with chemotherapies gemcitabine and cisplatin against stage IV squamous non-small cell lung cancer. With addition of necitumumab, median overall survival was 11.5 months compared with median survival of 9.9 months with the two chemotherapies alone.

11 Jun 2015

Paediatric outpatient study compares effectiveness of three alternative treatments for type 1 diabetes

A Montréal research team, co-supervised by Dr. Rémi Rabasa-Lhoret from the IRCM and Dr. Laurent Legault from the Montreal Children's Hospital, undertook the first paediatric outpatient study to compare three alternative treatments for type 1 diabetes.

11 Jun 2015

Brain changes reflect higher risk of cerebrovascular disease in women who experience more hot flashes

Women who experience more hot flashes, particularly while sleeping, during the menopause transition are more likely to have brain changes reflecting a higher risk for cerebrovascular disease, such as stroke and other brain blood flow problems, according to a pilot study led by researchers at the University of Pittsburgh School of Medicine published online today in Menopause and funded by the National Institutes of Health.

11 Jun 2015

Novel combination of non-toxic dietary and hyperbaric oxygen therapies doubles survival time in cancer model

A team of researchers from the Hyperbaric Biomedical Research Laboratory at the University of South Florida (USF) doubled survival time in an aggressive metastatic cancer model using a novel combination of non-toxic dietary and hyperbaric oxygen therapies.

11 Jun 2015

Autistic children who are sensitive to sensory stimuli have brains that react differently

Using functional magnetic resonance imaging, a team of UCLA researchers has shown for the first time that children with autism spectrum disorder (ASD) who are overly sensitive to sensory stimuli have brains that react differently than those with the disorder who don't respond so severely to noises, visual stimulation and physical contact.

11 Jun 2015

New approach to classifying brain tumors could lead to significant improvements in diagnosis, treatment

A Case Comprehensive Cancer Center brain surgeon and neurosurgery professor is among the primary authors of a new approach to classifying tumors that could lead to significant improvements in their diagnosis and treatment. The research and recommendations appear online June 10 in The New England Journal of Medicine.

11 Jun 2015

Findings point to new therapy against prostate and other cancers

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that a drug candidate with anticancer potential can be activated by one of the body's natural responses to cellular stress. Once activated, the agent can kill prostate cancer cells.

11 Jun 2015

Surgeons perform breakthrough operation to separate six-month-old conjoined Haitian twins

On Friday, May 22, an 18-member team of physicians and nurses from Children's Hospital Los Angeles (CHLA) and Keck Medicine of the University of Southern California (USC) led an international collaboration to separate a pair of six-month-old conjoined Haitian twins, the first such operation ever performed on Haitian soil.

11 Jun 2015

Initial therapy with DMARDs improves disease activity, functional ability in patients with early RA

The results of the tREACH trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that initial therapy with combination DMARDs significantly improves measures of disease activity and functional ability in patients with early rheumatoid arthritis (RA).

11 Jun 2015

Stage IIIB NSCLC patients may benefit from surgical resection in combination with chemo or radiation therapy

Patients diagnosed with an advanced form of metastatic non-small cell lung cancer (NSCLC) may benefit from surgical resection (removal of all or part of the lung) in combination with chemotherapy and radiation therapy, according to an article in the June 2015 issue of The Annals of Thoracic Surgery.

11 Jun 2015

UC San Diego researchers launch clinical trial to evaluate safety, efficacy of suramin drug for autism

Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety and efficacy of an unprecedented drug therapy for autism.

11 Jun 2015

WMMC expands use of capnography to monitor patient's breathing to control pain after surgery

White Memorial Medical Center recently strengthened patient safety measures by expanding its use of capnography to monitor patients using patient-controlled analgesia (PCA) to regulate their pain after surgery.

10 Jun 2015

INS announces winners of inaugural best abstract competition at 12th World Congress

The International Neuromodulation Society (INS) announced winners today of its inaugural best abstract competition at the 12th World Congress in Montreal.

10 Jun 2015

International Neuromodulation Society recognizes third Giant of Neuromodulation

The International Neuromodulation Society recognized its third Giant of Neuromodulation at its 12th World Congress in Montreal in June - the first such awardee who is renowned for work in neuromodulation for movement disorder. The honor was given to Prof. Alim-Louis Benabid, MD, PhD, board chairman of the biomedical research center Clinatec in Grenoble.

10 Jun 2015

Surgical resection, chemo and radiation therapy combination may help treat metastatic lung cancer

10 Jun 2015

FDA agrees to Oncogenex' proposed amendment to Phase 3 AFFINITY protocol

OncoGenex Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has agreed to the Company's proposed amendment to the Phase 3 AFFINITY protocol and statistical analysis plan.

10 Jun 2015

E-QURE inks distribution agreement with Rubifarm S.A.

E-QURE Corp. (OTCQB: EQUR), a Delaware Corporate engaged in the commercialization of its Bio-electrical Signal Therapy device ("BST Device"), a new and novel electrotherapy for the noninvasive treatment of hard to heal chronic wounds, today announced that the Company has signed its first distribution agreement with Rubifarm S.A., an Argentinian distributor specializing in medical devices, and. The agreement goes into effect immediately.

10 Jun 2015

$Full clinical trial feasible in refractory chronic angina pectoris$

Full clinical trial feasible in refractory chronic angina pectoris

Results of the world's first publicly funded randomized controlled clinical trial of spinal cord stimulation, being presented today at the 12th World Congress of the International Neuromodulation Society, conclude that a fully powered clinical trial is feasible in refractory chronic angina pectoris, a disabling and persistent chronic pain condition.

10 Jun 2015

New study finds growing use of CAM therapies among menopausal women

The use of complementary and alternative medicine (CAM) is increasing for the treatment of menopausal symptoms but often without the guidance of a clinician. That's according to a new study reported online today in Menopause, the journal of the North American Menopause Society.

10 Jun 2015

Therapy News and Research

Study reveals new information about role of abdominal fat in teens with CAH

SQUIRE phase III study shows necitumumab improves median overall survival in squamous NSCLC patients

Paediatric outpatient study compares effectiveness of three alternative treatments for type 1 diabetes

Brain changes reflect higher risk of cerebrovascular disease in women who experience more hot flashes

Novel combination of non-toxic dietary and hyperbaric oxygen therapies doubles survival time in cancer model

Autistic children who are sensitive to sensory stimuli have brains that react differently

New approach to classifying brain tumors could lead to significant improvements in diagnosis, treatment

Findings point to new therapy against prostate and other cancers

Surgeons perform breakthrough operation to separate six-month-old conjoined Haitian twins

Initial therapy with DMARDs improves disease activity, functional ability in patients with early RA

Stage IIIB NSCLC patients may benefit from surgical resection in combination with chemo or radiation therapy

UC San Diego researchers launch clinical trial to evaluate safety, efficacy of suramin drug for autism

WMMC expands use of capnography to monitor patient's breathing to control pain after surgery

INS announces winners of inaugural best abstract competition at 12th World Congress

International Neuromodulation Society recognizes third Giant of Neuromodulation

Surgical resection, chemo and radiation therapy combination may help treat metastatic lung cancer

FDA agrees to Oncogenex' proposed amendment to Phase 3 AFFINITY protocol

E-QURE inks distribution agreement with Rubifarm S.A.

Full clinical trial feasible in refractory chronic angina pectoris

New study finds growing use of CAM therapies among menopausal women

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News